Vincerx Pharma Stock Price Prediction

VINC Stock  USD 1.50  0.06  3.85%   
At the present time, the RSI of Vincerx Pharma's share price is approaching 35. This entails that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Vincerx Pharma, making its price go up or down.

Oversold Vs Overbought

35

 
Oversold
 
Overbought
The successful prediction of Vincerx Pharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Vincerx Pharma, which may create opportunities for some arbitrage if properly timed.
Using Vincerx Pharma hype-based prediction, you can estimate the value of Vincerx Pharma from the perspective of Vincerx Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Vincerx Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Vincerx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Vincerx Pharma after-hype prediction price

    
  USD 2.16  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Vincerx Pharma Basic Forecasting Models to cross-verify your projections.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.
Intrinsic
Valuation
LowRealHigh
0.132.6814.42
Details
Naive
Forecast
LowNextHigh
0.021.0212.76
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.293.515.73
Details

Vincerx Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Vincerx Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vincerx Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vincerx Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Vincerx Pharma Estimiated After-Hype Price Volatility

In the context of predicting Vincerx Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vincerx Pharma's historical news coverage. Vincerx Pharma's after-hype downside and upside margins for the prediction period are 0.11 and 13.90, respectively. We have considered Vincerx Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.50
2.16
After-hype Price
13.90
Upside
Vincerx Pharma is extremely dangerous at this time. Analysis and calculation of next after-hype price of Vincerx Pharma is based on 3 months time horizon.

Vincerx Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Vincerx Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vincerx Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vincerx Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  2.04 
11.64
 0.00  
  0.02 
0 Events / Month
2 Events / Month
Any time
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.50
2.16
35.00 
0.00  
Notes

Vincerx Pharma Hype Timeline

Vincerx Pharma is at this time traded for 1.50. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Vincerx is estimated to increase in value after the next headline, with the price projected to jump to 2.16 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is projected to be 35.0%, whereas the daily expected return is at this time at -2.04%. The volatility of related hype on Vincerx Pharma is about 134778.95%, with the expected price after the next announcement by competition of 1.52. Vincerx Pharma currently holds 2.5 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Vincerx Pharma has a current ratio of 7.72, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Vincerx Pharma's use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next estimated press release will be any time.
Check out Vincerx Pharma Basic Forecasting Models to cross-verify your projections.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.

Vincerx Pharma Related Hype Analysis

Having access to credible news sources related to Vincerx Pharma's direct competition is more important than ever and may enhance your ability to predict Vincerx Pharma's future price movements. Getting to know how Vincerx Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vincerx Pharma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SPROSpero Therapeutics 0.00 0 per month 0.00 (0.16) 4.85 (4.76) 17.35 
BOLTBolt Biotherapeutics 0.00 0 per month 0.00 (0.16) 5.00 (6.45) 16.07 
CHRSCoherus BioSciences 0.00 0 per month 4.28  0.15  13.89 (8.00) 45.84 
GRCLGracell Biotechnologies 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NLTXNeoleukin Therapeutics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
APLTApplied Therapeutics 0.00 0 per month 0.00 (0.30) 4.92 (13.79) 82.78 
LYRALyra Therapeutics 0.00 0 per month 0.00 (0.08) 5.88 (10.00) 32.42 
STTKShattuck Labs 0.00 0 per month 5.07  0.01  10.74 (9.01) 22.78 
BCABBioatla 0.00 0 per month 0.00 (0.29) 7.77 (11.59) 54.97 
MNPRMonopar Therapeutics 0.18 8 per month 11.56  0.09  14.92 (14.84) 48.16 
SNTISenti Biosciences 0.00 0 per month 6.53  0.10  11.46 (11.96) 391.56 
PCSAProcessa Pharmaceuticals 0.00 0 per month 0.00 (0.14) 10.34 (9.57) 32.56 
FRTXFresh Tracks Therapeutics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
LVTXLAVA Therapeutics NV 0.01 5 per month 0.00 (0.20) 7.91 (8.11) 34.81 
TCONTRACON Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
RZLTRezolute 0.00 0 per month 0.00 (0.04) 6.80 (5.95) 19.56 
XOMAXOMA Corp 0.00 0 per month 0.00 (0.1) 5.16 (4.96) 16.18 
SIOXSio Gene Therapies 0.00 5 per month 0.00 (0.16) 2.44 (4.44) 11.21 
TARAProtara Therapeutics 0.00 0 per month 4.29  0.12  12.86 (7.16) 78.24 
VCNXVaccinex 0.00 0 per month 0.00 (0.11) 12.36 (16.55) 75.17 
MIROMiromatrix Medical 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SRZNSurrozen 0.00 0 per month 6.07  0  19.37 (10.20) 37.14 

Vincerx Pharma Additional Predictive Modules

Most predictive techniques to examine Vincerx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vincerx using various technical indicators. When you analyze Vincerx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Vincerx Pharma Predictive Indicators

The successful prediction of Vincerx Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vincerx Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vincerx Pharma based on analysis of Vincerx Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vincerx Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vincerx Pharma's related companies.

Story Coverage note for Vincerx Pharma

The number of cover stories for Vincerx Pharma depends on current market conditions and Vincerx Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vincerx Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vincerx Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Vincerx Pharma Short Properties

Vincerx Pharma's future price predictability will typically decrease when Vincerx Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vincerx Pharma often depends not only on the future outlook of the potential Vincerx Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vincerx Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding21.3 M
Cash And Short Term Investments12.8 M

Complementary Tools for Vincerx Stock analysis

When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope